Leslie Nelson

2.3k total citations
26 papers, 256 citations indexed

About

Leslie Nelson is a scholar working on Genetics, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Leslie Nelson has authored 26 papers receiving a total of 256 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Genetics, 9 papers in Molecular Biology and 7 papers in Psychiatry and Mental health. Recurrent topics in Leslie Nelson's work include Neurogenetic and Muscular Disorders Research (16 papers), Cerebral Palsy and Movement Disorders (7 papers) and Muscle Physiology and Disorders (6 papers). Leslie Nelson is often cited by papers focused on Neurogenetic and Muscular Disorders Research (16 papers), Cerebral Palsy and Movement Disorders (7 papers) and Muscle Physiology and Disorders (6 papers). Leslie Nelson collaborates with scholars based in United States, United Kingdom and Australia. Leslie Nelson's co-authors include Susan T. Iannaccone, Linda S. Hynan, Richard S. Finkel, Allan M. Glanzman, Suzann K. Campbell, Angela Sanguinetti, Tina Duong, Sally Dunaway Young, Craig M. McDonald and Basil T. Darras and has published in prestigious journals such as PLoS ONE, Neurology and International Journal of Molecular Sciences.

In The Last Decade

Leslie Nelson

21 papers receiving 248 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leslie Nelson United States 9 137 115 67 36 28 26 256
Aga Lewelt United States 6 174 1.3× 158 1.4× 94 1.4× 48 1.3× 12 0.4× 6 328
Maria Teresa Arnoldi Italy 9 184 1.3× 164 1.4× 99 1.5× 35 1.0× 11 0.4× 14 270
Lavinia Fanelli Italy 10 193 1.4× 147 1.3× 130 1.9× 28 0.8× 13 0.5× 19 288
Jean Flickinger United States 5 145 1.1× 156 1.4× 96 1.4× 19 0.5× 8 0.3× 8 248
Zorica Stević Serbia 14 142 1.0× 97 0.8× 38 0.6× 21 0.6× 8 0.3× 39 522
Marc‐Olivier Deguise Canada 13 307 2.2× 246 2.1× 118 1.8× 17 0.5× 19 0.7× 25 405
Maria Sframeli Italy 11 282 2.1× 269 2.3× 171 2.6× 10 0.3× 31 1.1× 27 441
Crystal M. Proud United States 9 124 0.9× 170 1.5× 68 1.0× 13 0.4× 12 0.4× 25 281
Olivia Schreiber‐Katz Germany 13 365 2.7× 269 2.3× 163 2.4× 30 0.8× 43 1.5× 29 511
Filippo Buccella Italy 5 53 0.4× 160 1.4× 11 0.2× 20 0.6× 13 0.5× 9 222

Countries citing papers authored by Leslie Nelson

Since Specialization
Citations

This map shows the geographic impact of Leslie Nelson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leslie Nelson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leslie Nelson more than expected).

Fields of papers citing papers by Leslie Nelson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leslie Nelson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leslie Nelson. The network helps show where Leslie Nelson may publish in the future.

Co-authorship network of co-authors of Leslie Nelson

This figure shows the co-authorship network connecting the top 25 collaborators of Leslie Nelson. A scholar is included among the top collaborators of Leslie Nelson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leslie Nelson. Leslie Nelson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nelson, Leslie, Robert Adamu Shey, Kristiaan Demeyer, et al.. (2025). Targeted Sequencing Identifies SNPs Associated with Antimalarial Drug Resistance and the CSP Vaccine Antigen in Plasmodium falciparum from Southwest Cameroon. International Journal of Molecular Sciences. 26(21). 10764–10764.
2.
3.
Crawford, Thomas O., Basil T. Darras, John Day, et al.. (2024). Safety and Efficacy of Apitegromab in Patients With Spinal Muscular Atrophy Types 2 and 3. Neurology. 102(5). e209151–e209151. 19 indexed citations
4.
Nelson, Leslie, et al.. (2024). 218P Inter-rater reliability of adapted test of neuromuscular disorders (ATEND) wheelchair-based assessment. Neuromuscular Disorders. 43. 104441.60–104441.60.
5.
Servais, Laurent, Michelle A. Farrar, D. Vlodavets, et al.. (2024). 21O RAINBOWFISH: 2-year efficacy and safety data of risdiplam in infants with presymptomatic SMA. Neuromuscular Disorders. 43. 104441.738–104441.738.
6.
Lowes, Linda, Michelle K. White, Lindsay N. Alfano, et al.. (2022). Development of Duchenne Video Assessment scorecards to evaluate ease of movement among those with Duchenne muscular dystrophy. PLoS ONE. 17(4). e0266845–e0266845. 5 indexed citations
7.
Duong, Tina, Marisa Birkmeier, Leslie Nelson, et al.. (2021). The Minimal Clinical Important Difference (MCID) in Annual Rate of Change of Timed Function Tests in Boys with DMD. Journal of Neuromuscular Diseases. 8(6). 939–948. 13 indexed citations
8.
Duong, Tina, Kristin J. Krosschell, M. James, et al.. (2021). Consensus Guidelines for Improving Quality of Assessment and Training for Neuromuscular Diseases. Frontiers in Genetics. 12. 735936–735936. 4 indexed citations
9.
Nelson, Leslie & Susan T. Iannaccone. (2021). Clinical outcome assessments in Duchenne muscular dystrophy and spinal muscular atrophy: past, present and future. Neuromuscular Disorders. 31(10). 1028–1037. 2 indexed citations
10.
Nelson, Leslie & Susan T. Iannaccone. (2021). Social Media and Clinical Trials in Pediatric Disease: Musings From the Bench. Frontiers in Genetics. 12. 734691–734691. 2 indexed citations
11.
Servais, Laurent, Mohammad A. Al–Muhaizea, Michelle A. Farrar, et al.. (2021). CLINICAL TRIAL HIGHLIGHTS. Neuromuscular Disorders. 31. S48–S48. 2 indexed citations
12.
Berti, Beatrice, Mohammad A. Al–Muhaizea, Michelle A. Farrar, et al.. (2021). RAINBOWFISH: A study of risdiplam in infants with presymptomatic SMA. 1 indexed citations
13.
Connolly, Anne M., Craig M. Zaidman, Paul T. Golumbek, et al.. (2019). Twice‐weekly glucocorticosteroids in infants and young boys with Duchenne muscular dystrophy. Muscle & Nerve. 59(6). 650–657. 28 indexed citations
14.
Lowes, Linda, Lindsay N. Alfano, Leslie Nelson, et al.. (2019). P.214Presymptomatic spinal muscular atrophy: reality or myth?. Neuromuscular Disorders. 29. S129–S129.
15.
Glanzman, Allan M., Elena Mazzone, Sally Dunaway Young, et al.. (2018). Evaluator Training and Reliability for SMA Global Nusinersen Trials. Journal of Neuromuscular Diseases. 5(2). 159–166. 29 indexed citations
16.
Chen, David, Steve Rust, En‐Ju D. Lin, et al.. (2018). Prediction of Clinical Outcomes of Spinal Muscular Atrophy Using Motion Tracking Data and Elastic Net Regression. 474–481. 1 indexed citations
17.
Nelson, Leslie, Dayna S. Early, & Susan T. Iannaccone. (2013). P.7.14 Effects of a regular aquatic therapy program on one individual with Duchenne Muscular Dystrophy (DMD): A case study. Neuromuscular Disorders. 23(9-10). 777–778. 2 indexed citations
18.
Xavier, Guilherme B., et al.. (2010). Performance and Reliability of Modules with Anti-Reflective Coated Glass. EU PVSEC. 4103–4106. 6 indexed citations
19.
Finkel, Richard S., Linda S. Hynan, Allan M. Glanzman, et al.. (2008). The Test of Infant Motor Performance: Reliability in Spinal Muscular Atrophy Type I. Pediatric Physical Therapy. 20(3). 242–246. 35 indexed citations
20.
Nelson, Leslie, et al.. (2006). The gross motor function measure™ is a valid and sensitive outcome measure for spinal muscular atrophy. Neuromuscular Disorders. 16(6). 374–380. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aga Lewelt Breakdown of academic impact, for papers by Maria Teresa Arnoldi Breakdown of academic impact, for papers by Lavinia Fanelli Breakdown of academic impact, for papers by Jean Flickinger Breakdown of academic impact, for papers by Zorica Stević Breakdown of academic impact, for papers by Marc‐Olivier Deguise Breakdown of academic impact, for papers by Maria Sframeli Breakdown of academic impact, for papers by Crystal M. Proud Breakdown of academic impact, for papers by Olivia Schreiber‐Katz Breakdown of academic impact, for papers by Filippo Buccella
Rankless by CCL
2026